William F. Maragos - Publications

University of Kentucky, Lexington, KY 
Toxicology, Neuroscience Biology, Virology Biology

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2012 Theodore S, Cass WA, Dwoskin LP, Maragos WF. HIV-1 protein Tat inhibits vesicular monoamine transporter-2 activity in rat striatum. Synapse (New York, N.Y.). 66: 755-7. PMID 22517264 DOI: 10.1002/syn.21564  0.48
2007 Korde AS, Pettigrew LC, Craddock SD, Pocernich CB, Waldmeier PC, Maragos WF. Protective effects of NIM811 in transient focal cerebral ischemia suggest involvement of the mitochondrial permeability transition. Journal of Neurotrauma. 24: 895-908. PMID 17518543 DOI: 10.1089/neu.2006.0122  0.48
2007 Pandya JD, Pauly JR, Nukala VN, Sebastian AH, Day KM, Korde AS, Maragos WF, Hall ED, Sullivan PG. Post-Injury Administration of Mitochondrial Uncouplers Increases Tissue Sparing and Improves Behavioral Outcome following Traumatic Brain Injury in Rodents. Journal of Neurotrauma. 24: 798-811. PMID 17518535 DOI: 10.1089/neu.2006.3673  0.48
2007 Theodore S, Cass WA, Nath A, Maragos WF. Progress in understanding basal ganglia dysfunction as a common target for methamphetamine abuse and HIV-1 neurodegeneration. Current Hiv Research. 5: 301-13. PMID 17504172 DOI: 10.2174/157016207780636515  0.48
2007 Hauser KF, El-Hage N, Stiene-Martin A, Maragos WF, Nath A, Persidsky Y, Volsky DJ, Knapp PE. HIV-1 neuropathogenesis: glial mechanisms revealed through substance abuse. Journal of Neurochemistry. 100: 567-86. PMID 17173547 DOI: 10.1111/j.1471-4159.2006.04227.x  0.48
2006 Berman JW, Carson MJ, Chang L, Cox BM, Fox HS, Gonzalez RG, Hanson GR, Hauser KF, Ho WZ, Hong JS, Major EO, Maragos WF, Masliah E, McArthur JC, Miller DB, et al. NeuroAIDS, drug abuse, and inflammation: building collaborative research activities. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 1: 351-99. PMID 18040811 DOI: 10.1007/s11481-006-9048-9  0.48
2006 Theodore S, Stolberg S, Cass WA, Maragos WF. Human immunodeficiency virus-1 protein tat and methamphetamine interactions. Annals of the New York Academy of Sciences. 1074: 178-90. PMID 17105916 DOI: 10.1196/annals.1369.018  0.48
2006 Theodore S, Cass WA, Nath A, Steiner J, Young K, Maragos WF. Inhibition of tumor necrosis factor-alpha signaling prevents human immunodeficiency virus-1 protein Tat and methamphetamine interaction. Neurobiology of Disease. 23: 663-8. PMID 16828290 DOI: 10.1016/j.nbd.2006.05.005  0.48
2006 Theodore S, Cass WA, Maragos WF. Involvement of cytokines in human immunodeficiency virus-1 protein Tat and methamphetamine interactions in the striatum. Experimental Neurology. 199: 490-8. PMID 16510141 DOI: 10.1016/j.expneurol.2006.01.009  0.48
2006 Theodore S, Cass WA, Maragos WF. Methamphetamine and human immunodeficiency virus protein Tat synergize to destroy dopaminergic terminals in the rat striatum. Neuroscience. 137: 925-35. PMID 16338084 DOI: 10.1016/j.neuroscience.2005.10.056  0.48
2005 Korde AS, Sullivan PG, Maragos WF. The uncoupling agent 2,4-dinitrophenol improves mitochondrial homeostasis following striatal quinolinic acid injections. Journal of Neurotrauma. 22: 1142-9. PMID 16238490 DOI: 10.1089/neu.2005.22.1142  0.48
2005 Korde AS, Pettigrew LC, Craddock SD, Maragos WF. The mitochondrial uncoupler 2,4-dinitrophenol attenuates tissue damage and improves mitochondrial homeostasis following transient focal cerebral ischemia. Journal of Neurochemistry. 94: 1676-84. PMID 16045446 DOI: 10.1111/j.1471-4159.2005.03328.x  0.48
2004 Jin Y, McEwen ML, Nottingham SA, Maragos WF, Dragicevic NB, Sullivan PG, Springer JE. The mitochondrial uncoupling agent 2,4-dinitrophenol improves mitochondrial function, attenuates oxidative damage, and increases white matter sparing in the contused spinal cord. Journal of Neurotrauma. 21: 1396-404. PMID 15672630 DOI: 10.1089/neu.2004.21.1396  0.48
2004 Maragos WF, Young KL, Altman CS, Pocernich CB, Drake J, Butterfield DA, Seif I, Holschneider DP, Chen K, Shih JC. Striatal damage and oxidative stress induced by the mitochondrial toxin malonate are reduced in clorgyline-treated rats and MAO-A deficient mice. Neurochemical Research. 29: 741-6. PMID 15098936 DOI: 10.1023/B:NERE.0000018845.82808.45  0.48
2003 Cass WA, Harned ME, Peters LE, Nath A, Maragos WF. HIV-1 protein Tat potentiation of methamphetamine-induced decreases in evoked overflow of dopamine in the striatum of the rat. Brain Research. 984: 133-42. PMID 12932847 DOI: 10.1016/S0006-8993(03)03122-6  0.48
2002 Maragos WF, Young KL, Turchan JT, Guseva M, Pauly JR, Nath A, Cass WA. Human immunodeficiency virus-1 Tat protein and methamphetamine interact synergistically to impair striatal dopaminergic function. Journal of Neurochemistry. 83: 955-63. PMID 12421368 DOI: 10.1046/j.1471-4159.2002.01212.x  0.48
2002 Maragos WF, Zhu J, Chesnut MD, Dwoskin LP. Mitochondrial toxin inhibition of [(3)H]dopamine uptake into rat striatal synaptosomes. Biochemical Pharmacology. 63: 1499-505. PMID 11996892 DOI: 10.1016/S0006-2952(02)00910-3  0.48
Show low-probability matches.